Bristol-Myers Squibb Company

Organization

New York, NY, US

Ticker Symbols

NYSE:BMY

PHARMACEUTICAL PREPARATIONS
Business Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
Mailing Address
430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
State Location
NY
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Antisense oligonucleotides targeting alpha-synuclein and uses thereof
- Patent number 12,180,478
- Issue date Dec 31, 2024
- Bristol-Myers Squibb Company
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combinatorial drug delivery device
- Patent number 12,178,781
- Issue date Dec 31, 2024
- Bristol-Myers Squibb Company
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1H-indazole carboxamides as receptor-interacting protein kinase 1 i...
- Patent number 12,172,975
- Issue date Dec 24, 2024
- Bristol-Myers Squibb Company
- Junqing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted indole and indazole compounds
- Patent number 12,172,995
- Issue date Dec 24, 2024
- Bristol-Myers Squibb Company
- John L. Gilmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to vista at acidic pH
- Patent number 12,173,069
- Issue date Dec 24, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of measuring hydrophobicity of chromatographic resins
- Patent number 12,174,161
- Issue date Dec 24, 2024
- Bristol-Myers Squibb Company
- Chao Huang
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Apelin receptor agonists and methods of use
- Patent number 12,168,655
- Issue date Dec 17, 2024
- Bristol-Myers Squibb Company
- Wei Meng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of protein tyrosine phosphatase, compositions, and metho...
- Patent number 12,162,848
- Issue date Dec 10, 2024
- Bristol-Myers Squibb Company
- Haibo Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of alkaline washes during chromatography to remove impurities
- Patent number 12,157,073
- Issue date Dec 3, 2024
- Bristol-Myers Squibb Company
- Jue Wang
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Grant
Aminotriazolopyridines as kinase inhibitors
- Patent number 12,157,733
- Issue date Dec 3, 2024
- Bristol-Myers Squibb Company
- Junqing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of renal cell carcinoma
- Patent number 12,152,075
- Issue date Nov 26, 2024
- Bristol-Myers Squibb Company
- Jason Samuel Simon
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Framework for document layout and information extraction
- Patent number 12,154,362
- Issue date Nov 26, 2024
- Bristol-Myers Squibb Company
- Mark Salacinski
- G06 - COMPUTING CALCULATING COUNTING
Information Patent Grant
Inhibitors of indoleamine 2,3-dioxygenase and methods of their use
- Patent number 12,145,927
- Issue date Nov 19, 2024
- Bristol-Myers Squibb Company
- James Aaron Balog
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-IDO antibody and uses thereof
- Patent number 12,139,551
- Issue date Nov 12, 2024
- Bristol-Myers Squibb Company
- Anan Chuntharapai
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of a PAR4 inhibitor
- Patent number 12,129,264
- Issue date Oct 29, 2024
- Bristol-Myers Squibb Company
- Roxana F. Schlam
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 12,129,297
- Issue date Oct 29, 2024
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-meth...
- Patent number 12,129,245
- Issue date Oct 29, 2024
- Bristol-Myers Squibb Company
- Victor W. Rosso
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD27 antibodies and uses thereof
- Patent number 12,110,337
- Issue date Oct 8, 2024
- Bristol-Myers Squibb Company
- Li-Sheng Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Triazolopyridinyl compounds as kinase inhibitors
- Patent number 12,110,290
- Issue date Oct 8, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protein recovery
- Patent number 12,103,949
- Issue date Oct 1, 2024
- Bristol-Myers Squibb Company
- Abhiram Arunkumar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Serially-connectable drug modules for combinatorial drug delivery d...
- Patent number 12,102,595
- Issue date Oct 1, 2024
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Automated parallel autosampler system and method for drawing chroma...
- Patent number 12,099,041
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Cristopher Hollander
- G01 - MEASURING TESTING
Information Patent Grant
Treatment of fibrosis, cardiovascular disease and heart failure wit...
- Patent number 12,097,242
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating kidney failure, and/or improving or stablizing...
- Patent number 12,097,241
- Issue date Sep 24, 2024
- Bristol-Myers Squibb Company
- Gene M. Dubowchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding to vista at acidic pH
- Patent number 12,091,462
- Issue date Sep 17, 2024
- Five Prime Therapeutics, Inc.
- Robert J. Johnston
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazothiadiazole and imidazopyrazine derivatives as protease acti...
- Patent number 12,084,452
- Issue date Sep 10, 2024
- Bristol-Myers Squibb Company
- Jacques Banville
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Indazole carboxamides as kinase inhibitors
- Patent number 12,084,426
- Issue date Sep 10, 2024
- Bristol-Myers Squibb Company
- Junqing Guo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Assay to determine in vivo receptor occupancy
- Patent number 12,085,564
- Issue date Sep 10, 2024
- Bristol-Myers Squibb Company
- Naiyu Zheng
- G01 - MEASURING TESTING
Information Patent Grant
Methods of treating HLA-E-expressing cancers by administering antib...
- Patent number 12,077,584
- Issue date Sep 3, 2024
- Bristol-Myers Squibb Company
- Natalie Bezman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Classifying pharmacovigilance documents using image analysis
- Patent number 12,080,087
- Issue date Sep 3, 2024
- Bristol-Myers Squibb Company
- Sameen Mayur Desai
- G06 - COMPUTING CALCULATING COUNTING

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS
- Publication number 20240425505
- Publication date Dec 26, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY D...
- Publication number 20240415736
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING
- Publication number 20240417471
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- John P. COGSWELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER
- Publication number 20240417473
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Shivani SRIVASTAVA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND USES THEREOF
- Publication number 20240417478
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Aaron Paul Yamniuk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RXFP1 AGONISTS
- Publication number 20240417369
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Donald J. P. Pinto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER
- Publication number 20240417465
- Publication date Dec 19, 2024
- Bristol-Myers Squibb Company
- Laurence David TOMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC IMMUNOMODULATORS
- Publication number 20240409585
- Publication date Dec 12, 2024
- Bristol-Myers Squibb Company
- Martin Patrick ALLEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS
- Publication number 20240400563
- Publication date Dec 5, 2024
- Bristol-Myers Squibb Company
- Upender Velaparthi
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING HAIR-LOSS DISORDERS WITH TYK2 INHIBITORS
- Publication number 20240390372
- Publication date Nov 28, 2024
- Bristol-Myers Squibb Company
- Ian MacQuarie Catlett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS
- Publication number 20240391931
- Publication date Nov 28, 2024
- Bristol-Myers Squibb Company
- Laura Akullian D'Agostino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DRUG CARTRIDGE, DRUG DELIVERY DEVICE, AND METHODS FOR PREPARING THE...
- Publication number 20240390580
- Publication date Nov 28, 2024
- Bristol-Myers Squibb Company
- Martin John McLoughlin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF CONTROLLING THE LEVEL OF DISSOLVED OXYGEN (DO) IN A SOLU...
- Publication number 20240390869
- Publication date Nov 28, 2024
- Bristol-Myers Squibb Company
- Danielle BELLUSCIO
- B01 - PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
Information Patent Application
METHODS FOR DETERMINING RESPONSIVENESS TO TYK2 INHIBITORS
- Publication number 20240390369
- Publication date Nov 28, 2024
- Bristol-Myers Squibb Company
- Yanhua Hu
- G01 - MEASURING TESTING
Information Patent Application
IONIZABLE LIPIDS
- Publication number 20240390284
- Publication date Nov 28, 2024
- Bristol-Myers Squibb Company
- Kendall Condon
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUND USEFUL FOR PET-IMAGING OF BRUTON’S TYROSINE KINASE
- Publication number 20240383871
- Publication date Nov 21, 2024
- Bristol-Myers Squibb Company
- David J. Donnelly
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS
- Publication number 20240376082
- Publication date Nov 14, 2024
- Bristol-Myers Squibb Company
- Yan Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES
- Publication number 20240377413
- Publication date Nov 14, 2024
- Bristol-Myers Squibb Company
- Srikanth KOTAPATI
- G01 - MEASURING TESTING
Information Patent Application
CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3- (1-ME...
- Publication number 20240368130
- Publication date Nov 7, 2024
- Bristol-Myers Squibb Company
- Chenkou Wei
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC IMMUNOMODULATORS
- Publication number 20240360178
- Publication date Oct 31, 2024
- Bristol-Myers Squibb Company
- Martin Patrick ALLEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIARYL KINASE INHIBITORS
- Publication number 20240360131
- Publication date Oct 31, 2024
- Bristol-Myers Squibb Company
- Guanglin Luo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN...
- Publication number 20240360235
- Publication date Oct 31, 2024
- Bristol-Myers Squibb Company
- Vladimir CORIC
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TO CD40
- Publication number 20240336695
- Publication date Oct 10, 2024
- Bristol-Myers Squibb Company
- Bryan C. BARNHART
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds and Compositions for Selective Degradation of Engineered...
- Publication number 20240327381
- Publication date Oct 3, 2024
- Celgene Corporation
- Laura Akullian D'Agostino
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HIGH-AFFINITY SUPRAMOLECULAR POLYMERS FOR BINDING-TRIGGERED ANTIBOD...
- Publication number 20240327455
- Publication date Oct 3, 2024
- The Johns Hopkins University
- Honggang Cui
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES
- Publication number 20240325388
- Publication date Oct 3, 2024
- Bristol-Myers Squibb Company
- Umesh Kestur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS FOR THE TREATMENT OF DISEASE
- Publication number 20240325495
- Publication date Oct 3, 2024
- Bristol-Myers Squibb Company
- Alice L. WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LACTONE AND LACTAM CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS
- Publication number 20240327389
- Publication date Oct 3, 2024
- Bristol-Myers Squibb Company
- TAO WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED NITROGEN CONTAINING COMPOUNDS
- Publication number 20240327390
- Publication date Oct 3, 2024
- Bristol-Myers Squibb Company
- Navnath Dnyanoba Yadav
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20240317718
- Publication date Sep 26, 2024
- Bristol-Myers Squibb Company
- STEVEN H. SPERGEL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
98880509 - ADLYVIG
- Serial number 98880509
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880523 - EXHALZIG
- Serial number 98880523
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880531 - FREOFIBE
- Serial number 98880531
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880581 - ONWINGA
- Serial number 98880581
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880595 - REXHYLA
- Serial number 98880595
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880609 - WYNGARIZE
- Serial number 98880609
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880536 - INERBREZE
- Serial number 98880536
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880515 - EXHALSIG
- Serial number 98880515
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880545 - LIBHAYLS
- Serial number 98880545
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880559 - LUPAVEO
- Serial number 98880559
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880569 - MYSPIRIC
- Serial number 98880569
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880602 - WINGARYZ
- Serial number 98880602
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880605 - ZUBRIHALE
- Serial number 98880605
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880539 - LEXHAYLZ
- Serial number 98880539
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880543 - LIBHALYF
- Serial number 98880543
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880575 - MYSPIRIQ
- Serial number 98880575
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880550 - LIBLUNIR
- Serial number 98880550
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880586 - RELFILPA
- Serial number 98880586
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98880590 - REXHILZA
- Serial number 98880590
- Filing date Dec 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98843459 - TYKCRAVA
- Serial number 98843459
- Filing date Nov 8, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98843463 - TYKRAVA
- Serial number 98843463
- Filing date Nov 8, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98826055 - ZOPDULAG
- Serial number 98826055
- Filing date Oct 29, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98782361 - RECHARGE
- Serial number 98782361
- Filing date Oct 2, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98735815 - OPDYTA
- Serial number 98735815
- Filing date Sep 5, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472299 - DURELIMMU
- Serial number 98472299
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472311 - DURLAGNIV
- Serial number 98472311
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472315 - LAGIMMU
- Serial number 98472315
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472326 - BAMBROVA
- Serial number 98472326
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472301 - LAGDURITY
- Serial number 98472301
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98472305 - RELOPDUO
- Serial number 98472305
- Filing date Mar 28, 2024
- BRISTOL-MYERS SQUIBB COMPANY
- 5 - Pharmaceutical and veterinary preparations

Bristol-Myers Squibb Company

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

Combinatorial drug delivery device

1H-indazole carboxamides as receptor-interacting protein kinase 1 i...

Substituted indole and indazole compounds

Antibodies binding to vista at acidic pH

Methods of measuring hydrophobicity of chromatographic resins

Apelin receptor agonists and methods of use

Inhibitors of protein tyrosine phosphatase, compositions, and metho...

Use of alkaline washes during chromatography to remove impurities

Aminotriazolopyridines as kinase inhibitors

Treatment of renal cell carcinoma

Framework for document layout and information extraction

Inhibitors of indoleamine 2,3-dioxygenase and methods of their use

Anti-IDO antibody and uses thereof

Crystalline forms of a PAR4 inhibitor

Antibodies against TIM3 and uses thereof

Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-meth...

Anti-CD27 antibodies and uses thereof

Triazolopyridinyl compounds as kinase inhibitors

Protein recovery

Serially-connectable drug modules for combinatorial drug delivery d...

Automated parallel autosampler system and method for drawing chroma...

Treatment of fibrosis, cardiovascular disease and heart failure wit...

Methods of treating kidney failure, and/or improving or stablizing...

Antibodies binding to vista at acidic pH

Imidazothiadiazole and imidazopyrazine derivatives as protease acti...

Indazole carboxamides as kinase inhibitors

Assay to determine in vivo receptor occupancy

Methods of treating HLA-E-expressing cancers by administering antib...

Classifying pharmacovigilance documents using image analysis

Patents Applicationslast 30 patents

TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS

SERIALLY-CONNECTABLE DRUG MODULES FOR COMBINATORIAL DRUG DELIVERY D...

CANCER IMMUNOTHERAPY BY DISRUPTING PD-1/PD-L1 SIGNALING

LAG-3 ANTAGONIST THERAPY FOR HEMATOLOGICAL CANCER

ANTIBODIES AGAINST IL-7R ALPHA SUBUNIT AND USES THEREOF

RXFP1 AGONISTS

LAG-3 ANTAGONIST THERAPY FOR LUNG CANCER

MACROCYCLIC IMMUNOMODULATORS

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

METHODS OF TREATING HAIR-LOSS DISORDERS WITH TYK2 INHIBITORS

TRICYCLIC FUSED PYRIMIDINE COMPOUNDS FOR USE AS HER2 INHIBITORS

DRUG CARTRIDGE, DRUG DELIVERY DEVICE, AND METHODS FOR PREPARING THE...

METHODS OF CONTROLLING THE LEVEL OF DISSOLVED OXYGEN (DO) IN A SOLU...

METHODS FOR DETERMINING RESPONSIVENESS TO TYK2 INHIBITORS

IONIZABLE LIPIDS

COMPOUND USEFUL FOR PET-IMAGING OF BRUTON’S TYROSINE KINASE

PYRIDINYL SUBSTITUTED OXOISOINDOLINE COMPOUNDS

DUAL CAPTURE METHOD FOR ANALYSIS OF ANTIBODY-DRUG CONJUGATES

CRYSTAL FORMS OF 6-(CYCLOPROPANECARBOXAMIDO)-4-((2-METHOXY-3- (1-ME...

MACROCYCLIC IMMUNOMODULATORS

BIARYL KINASE INHIBITORS

USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN...

ANTIBODIES TO CD40

Compounds and Compositions for Selective Degradation of Engineered...

HIGH-AFFINITY SUPRAMOLECULAR POLYMERS FOR BINDING-TRIGGERED ANTIBOD...

DOSAGE FORMS FOR TYK2 INHIBITORS COMPRISING SWELLABLE CORES

FUSION PROTEINS FOR THE TREATMENT OF DISEASE

LACTONE AND LACTAM CONTAINING COMPOUNDS USEFUL AS IMMUNOMODULATORS

SUBSTITUTED NITROGEN CONTAINING COMPOUNDS

SUBSTITUTED HETEROCYCLIC COMPOUNDS

Trademarklast 30 trademarks

98880509 - ADLYVIG

98880523 - EXHALZIG

98880531 - FREOFIBE

98880581 - ONWINGA

98880595 - REXHYLA

98880609 - WYNGARIZE

98880536 - INERBREZE

98880515 - EXHALSIG

98880545 - LIBHAYLS

98880559 - LUPAVEO